How much did Warner Chilcott Ltd. acquired the prescription-drug business of Procter & Gamble Co.?
Sunday, according to The Wall Street Journal, specialty drug maker Warner Chilcott Ltd. (WCRX: News ) is acquiring the prescription-drug business of consumer goods giant Procter & Gamble Co. (PG: News ). The report stated that the pharmaceutical unit could fetch about $3 billion, and that the official announcement on a deal could be made as early as Monday. The company’s Ohio-based pharmaceutical unit was on the block for sale since December 2008. Ardee, Ireland-based Warner Chilcott, which recently shifted base from Rockaway, New Jersey, is expected to run the acquired business as a wholly-owned unit. Both the companies were unavailable to comment. The report stated that others in the fray to buy the unit were private equity firm Cerberus Capital Management LP and rival drug-maker Forest Laboratories Inc. (FRX). Analysts suggest that Warner Chilcott was at an advantage to win the deal as it is well positioned to squeeze maximum synergies and costs savings out of the acquisition. Warne
(RTTNews) – Sunday, according to The Wall Street Journal, specialty drug maker Warner Chilcott Ltd. (WCRX: News ) is acquiring the prescription-drug business of consumer goods giant Procter & Gamble Co. (PG: News ). The report stated that the pharmaceutical unit could fetch about $3 billion, and that the official announcement on a deal could be made as early as Monday. The company’s Ohio-based pharmaceutical unit was on the block for sale since December 2008. Ardee, Ireland-based Warner Chilcott, which recently shifted base from Rockaway, New Jersey, is expected to run the acquired business as a wholly-owned unit. Both the companies were unavailable to comment. The report stated that others in the fray to buy the unit were private equity firm Cerberus Capital Management LP and rival drug-maker Forest Laboratories Inc. (FRX). Analysts suggest that Warner Chilcott was at an advantage to win the deal as it is well positioned to squeeze maximum synergies and costs savings out of the acquis
